Wu S, Chen W
Nutrients. 2020; 12(9).
PMID: 32933151
PMC: 7551421.
DOI: 10.3390/nu12092803.
Dave R, Morris M
J Pharmacokinet Pharmacodyn. 2015; 42(5):497-513.
PMID: 26341876
PMC: 4761431.
DOI: 10.1007/s10928-015-9441-1.
KUH H, Shim C
Arch Pharm Res. 1994; 17(2):124-30.
PMID: 10319144
DOI: 10.1007/BF02974236.
Dalton J, Weintjes M, Au J
J Pharmacokinet Biopharm. 1994; 22(3):183-205.
PMID: 7884649
DOI: 10.1007/BF02353328.
Brashear R, Nelson R, Glick M, Oei T, DeAtley R
Lung. 1980; 158(2):101-9.
PMID: 7431995
DOI: 10.1007/BF02713709.
Measurement of excretion characteristics of theophylline and its major metabolites.
Jonkman J, Tang D, Upton R, RIEGELMAN S
Eur J Clin Pharmacol. 1981; 20(6):435-41.
PMID: 7286053
DOI: 10.1007/BF00542096.
Urine flow-dependence of theophylline renal clearance in man.
Tang-Liu D, Tozer T, RIEGELMAN S
J Pharmacokinet Biopharm. 1982; 10(4):351-64.
PMID: 7153869
DOI: 10.1007/BF01065168.
Pharmacokinetics of theophylline: a dose-range study.
Rovei V, CHANOINE F, Strolin Benedetti M
Br J Clin Pharmacol. 1982; 14(6):769-78.
PMID: 7150456
PMC: 1427546.
DOI: 10.1111/j.1365-2125.1982.tb02035.x.
Effect of chronic oral contraceptive steroids on theophylline disposition.
Tornatore K, Kanarkowski R, McCarthy T, Gardner M, Yurchak A, Jusko W
Eur J Clin Pharmacol. 1982; 23(2):129-34.
PMID: 7140802
DOI: 10.1007/BF00545966.
Pharmacokinetics of theophylline in infants with bronchiolitis.
Franko T, Powell D, Nahata M
Eur J Clin Pharmacol. 1982; 23(2):123-7.
PMID: 7140801
DOI: 10.1007/BF00545965.
The pharmacological role of the kidney.
Brater D
Drugs. 1980; 19(1):31-48.
PMID: 6988197
DOI: 10.2165/00003495-198019010-00003.
Non-linear elimination processes of theophylline.
Gundert-Remy U, Hildebrandt R, Hengen N, Weber E
Eur J Clin Pharmacol. 1983; 24(1):71-8.
PMID: 6832205
DOI: 10.1007/BF00613930.
Influence of chronic dosing on theophylline clearance.
Efthimiou H, Morgan D, Raymond K, McLean A
Br J Clin Pharmacol. 1984; 17(5):525-30.
PMID: 6733000
PMC: 1463460.
DOI: 10.1111/j.1365-2125.1984.tb02385.x.
Polymorphism of theophylline metabolism in man.
Miller C, Slusher L, Vesell E
J Clin Invest. 1985; 75(5):1415-25.
PMID: 4039734
PMC: 425478.
DOI: 10.1172/JCI111843.
Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.
Wagner J
Clin Pharmacokinet. 1985; 10(5):432-42.
PMID: 3899457
DOI: 10.2165/00003088-198510050-00005.
Effects of probenecid on enprofylline kinetics in man.
Borga O, Larsson R, Lunell E
Eur J Clin Pharmacol. 1986; 30(2):221-3.
PMID: 3709650
DOI: 10.1007/BF00614308.
Theophylline poisoning. Pharmacological considerations and clinical management.
Gaudreault P, Guay J
Med Toxicol. 1986; 1(3):169-91.
PMID: 3537617
DOI: 10.1007/BF03259836.
Absence of a clinically significant interaction between theophylline and furosemide.
Janicke U, Krudewagen B, Schulz A, Gundert-Remy U
Eur J Clin Pharmacol. 1987; 33(5):487-91.
PMID: 3428341
DOI: 10.1007/BF00544241.
Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.
Prandota J
Drugs. 1988; 35(5):542-78.
PMID: 3293970
DOI: 10.2165/00003495-198835050-00004.
Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).
Besunder J, Reed M, Blumer J
Clin Pharmacokinet. 1988; 14(5):261-86.
PMID: 3293867
DOI: 10.2165/00003088-198814050-00001.